iifl-logo

DSP Healthcare Fund Direct IDCW

DSP Healthcare Fund Direct IDCW

Fund Name

DSP Mutual Fund

Scheme Name

DSP Healthcare Fund Direct IDCW

AMC

DSP Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

12-Nov-2018

Fund Manager

Chirag Dagli

Net Assets (Rs. cr)

3114.33

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

DSP Healthcare Fund Direct IDCW - Nav Details

Nav Date

:  20-Jan-2026

NAV [Rs.]

:  26.301

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Nil

Exit Load %

1.00% - If redeemed/switched out within 12 months from the date of allotment. Nil - If redeemed/switched out after 12 months from the date of allotment.

DSP Healthcare Fund Direct IDCW- NAV Chart

DSP Healthcare Fund Direct IDCW- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
-2.25
-1.42
-1.34
-3.63
-3.68
22.04
16.06
22.59
Category Avg
-3.63
-4.32
-6.65
-6.75
-3.1
21.53
14.5
11.82
Category Best
-1.8
-1.42
-1.34
-3.63
2.66
26.79
17.08
25.96
Category Worst
-4.27
-5.99
-10.37
-11.09
-9.89
16.64
10.68
-8.91

DSP Healthcare Fund Direct IDCW- Latest Dividends

Record DateDividend %Bonus
24-Feb-2025230

DSP Healthcare Fund Direct IDCW- Investment Details

Min. Investment(Rs.)

100

Increm.Investment(Rs.)

100

In & Out

In

InName Of The CompanyNo Of Shares
Nephrocare Healt6,34,983
Corona Remedies1,16,970

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquityCiplaPharmaceuticals & Biotechnology8.691790481270.59
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology8.481535592264.07
EquityIpca Labs.Pharmaceuticals & Biotechnology7.731696381240.69
Foreign EquityGlobus Medical IncHealthcare Equipment & Supplies6.78268800211.03
EquityLaurus LabsPharmaceuticals & Biotechnology6.521832618203.05
Foreign EquityIllumina IncHealthcare Services6.07160400189.17
EquitySai LifePharmaceuticals & Biotechnology5.231792251162.80
EquityGland PharmaPharmaceuticals & Biotechnology5.09920673158.53
EquityCohance LifePharmaceuticals & Biotechnology5.042967600156.86
EquityApollo HospitalsHealthcare Services4.40194767137.16
EquityAlembic PharmaPharmaceuticals & Biotechnology3.881428180120.84
EquityPfizerPharmaceuticals & Biotechnology3.21200644100.07
EquityVijaya Diagnost.Healthcare Services3.1993553099.25
Foreign EquityIntuitive Surgical IncHealthcare Equipment & Supplies3.071876895.57
EquityKovai MedicalHealthcare Services3.0516515694.98
EquityP & G Health LtdPharmaceuticals & Biotechnology2.9215928890.84
EquityIndoco RemediesPharmaceuticals & Biotechnology2.44323347475.85
EquityConcord BiotechPharmaceuticals & Biotechnology2.1248977465.90
EquityEmcure PharmaPharmaceuticals & Biotechnology1.7038808752.95
EquityICICI LombardInsurance1.5224141347.36
EquityUnichem Labs.Pharmaceuticals & Biotechnology1.2185206337.64
Foreign EquityAbbott LaboratoriesPharmaceuticals & Biotechnology1.143160035.60
EquityAarti DrugsPharmaceuticals & Biotechnology1.1385215535.07
EquityNephrocare HealtHealthcare Services0.9663498329.76
EquityAlkem LabPharmaceuticals & Biotechnology0.663733420.55
EquityCorona RemediesPharmaceuticals & Biotechnology0.5211697016.19
EquityMedplus HealthRetailing0.5019207815.50
EquityJupiter Life LinHealthcare Services0.429411713.11
EquityLaxmi DentalHealthcare Equipment & Supplies0.252804017.63
Foreign EquityGrail IncHealthcare Services0.2287336.72
EquityThyrocare Tech.Healthcare Services0.06425731.89

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
DSP Mutual Fund
Incorporation Date:
13-May-1996
Total Assets Managed (Cr.):
2,24,668.94
Trustee/s:
Mr.T.S. Krishna Murthy, DSP Trustee Private Limit, Shitin D. Desai, S.S.N. Moorthy, Mrs. Pravin tripathi, Ms. Dharmishta Rawal
Chairman:
NA
CEO / MD:
Mr. Kalpen Parekh
CIO:
NA
President:
NA
Director/s:
Uday Khanna, Mr.Hemendra M. Kothari, Mr. S.S. Mundra, Ms. Aditi Kothari Desai, Mr.Dhananjay Mungale, Mr. S. Ramadorai
Compliance Officer/s:
Pritesh Majmudar
Investor Service Officer/s:
NA
Fund Manager/s:
Chirag Dagli
Auditors:
S.R. BATLIBOI &Co.LLP, M/s.Walker Chandiok & Co.

OTHER INFORMATION

Registered Office:
The Ruby, 25th Floor, 29, Senapati Bapat Marg, Dadar (West), Mumbai - 400028.
Contact Nos:
022-66578000
Fax:
022-66578181
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.